Pure Global

ETEST IMIPENEM / RELEBACTAM (IPR) - INVIMA Registration c298186436e3c33b3ebe76975b116d31

Access comprehensive regulatory information for ETEST IMIPENEM / RELEBACTAM (IPR) (ETEST IMIPENEM / RELEBACTAM (IPR) ) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID c298186436e3c33b3ebe76975b116d31 and manufactured by BIOMERIEUX SA. The device was registered on September 02, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.

Free Database
Powered by Pure Global AI
INVIMA Official Data
c298186436e3c33b3ebe76975b116d31
ETEST IMIPENEM / RELEBACTAM (IPR)
INVIMA Analysis ID: c298186436e3c33b3ebe76975b116d31
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Product Type (Spanish)
REACTIVO DIAGNOSTICO
Product Type (English)
DIAGNOSTIC REAGENT
Registration Information
Analysis ID
c298186436e3c33b3ebe76975b116d31
Expire Date
September 02, 2031
Authorized Company / Fabricante
Name (Spanish)
BIOMERIEUX SA
Name (English)
BIOMERIEUX SA